Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2015 16:05 ET | Source: Otonomy, Inc.

Otonomy Reports Phase 2b Topline Data for OTO-104 in Meniere's Disease

Narrowly missed primary endpoint of reduction in vertigo frequency during Month 3 following treatment compared to a one month baseline period, p = 0.067 Achieved statistical significance on...